Brainstorm Cell Therapeutics (BCLI) Q4 2025 Earnings

Nov 14Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.97
-0.71
-0.45
-0.19

Details

Expected EPS
-0.37
Actual EPS
-0.19
Surprise EPS
0.18
Surprise Percent
+48.65%

Description

⁨Brainstorm Cell Therapeutics⁩ (⁦BCLI⁩) has reported earnings of ⁦-0.19⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts